|
Alzheimer's disease
Citations 71-80 of 576 total displayed.
|
Past content
(since Jan 2001):
|
- VIEWS & REVIEWS
Vascular risk factors and dementia: How to move forward?
- Anand Viswanathan, Walter A. Rocca, and Christophe Tzourio
Neurology 2009; 72: 368-374.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Plasma Aβ, homocysteine, and cognition: The Vitamin Intervention for Stroke Prevention (VISP) trial
- A. Viswanathan, S. Raj, S. M. Greenberg, M. Stampfer, S. Campbell, B. T. Hyman, and M. C. Irizarry
Neurology 2009; 72: 268-272.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Postmenopausal hormone therapy and regional brain volumes: The WHIMS-MRI Study
- S. M. Resnick, M. A. Espeland, S. A. Jaramillo, C. Hirsch, M. L. Stefanick, A. M. Murray, J. Ockene, C. Davatzikos For the Women’s Health Initiative Memory Study
Neurology 2009; 72: 135-142.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Surrogate consent for dementia research: A national survey of older Americans
- S.Y.H. Kim, H. M. Kim, K. M. Langa, J. H.T. Karlawish, D. S. Knopman, and P. S. Appelbaum
Neurology 2009; 72: 149-155.
[Abstract]
[Full text]
[PDF]
- ARTICLE
Longitudinal prognostic value of serum "free" copper in patients with Alzheimer disease
- R. Squitti, F. Bressi, P. Pasqualetti, C. Bonomini, R. Ghidoni, G. Binetti, E. Cassetta, F. Moffa, M. Ventriglia, F. Vernieri, and P. M. Rossini
Neurology 2009; 72: 50-55.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Microglial activation and amyloid deposition in mild cognitive impairment: A PET study
- A. Okello, P. Edison, H. A. Archer, F. E. Turkheimer, J. Kennedy, R. Bullock, Z. Walker, A. Kennedy, N. Fox, M. Rossor, and D. J. Brooks
Neurology 2009; 72: 56-62.
[Abstract]
[Full text]
[PDF]
- ARTICLES
How redesigning AD clinical trials might increase study partners’ willingness to participate
- Jason Karlawish, Mark S. Cary, Jonathan Rubright, and Tom TenHave
Neurology 2008; 71: 1883-1888.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Cognitive profiles in dementia: Alzheimer disease vs healthy brain aging
- D. K. Johnson, M. Storandt, J. C. Morris, Z. D. Langford, and J. E. Galvin
Neurology 2008; 71: 1783-1789.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Growth hormone secretagogue MK-677: No clinical effect on AD progression in a randomized trial
- J. J. Sevigny, J. M. Ryan, C. H. van Dyck, Y. Peng, C. R. Lines, M. L. Nessly On behalf of the MK-677 Protocol 30 Study Group
Neurology 2008; 71: 1702-1708.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Medical decision-making capacity in mild cognitive impairment: A 3-year longitudinal study
- O. C. Okonkwo, H. R. Griffith, J. N. Copeland, K. Belue, S. Lanza, E. Y. Zamrini, L. E. Harrell, J. C. Brockington, D. Clark, R. Raman, and D. C. Marson
Neurology 2008; 71: 1474-1480.
[Abstract]
[Full text]
[PDF]
|
|
